Literature DB >> 30352675

Penetrance and Expressivity in Inherited Cancer Predisposing Syndromes.

Julia Taeubner1, Dagmar Wieczorek2, Layal Yasin1, Triantafyllia Brozou1, Arndt Borkhardt1, Michaela Kuhlen3.   

Abstract

Inherited diseases are not always expressed in the same way in every individual that carries the same variant in a disease-causing gene. This phenomenon is known as reduced or incomplete penetrance. Variable and incomplete penetrance may explain why inherited diseases are occasionally transmitted through unaffected parents, but also why clinically healthy individuals can carry potentially pathogenic variants without expressing features of the disease. Here, we will provide an overview of factors that play a fundamental role in the concept of penetrance and expressivity of cancer predisposing genes in children with malignancies. These findings are important to understand the complexity of inherited diseases and cancer development and to improve genetic counselling for the affected families.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cancer predisposition syndrome; children; expressivity; gene penetrance; genetic counselling; modifier genes

Mesh:

Year:  2018        PMID: 30352675     DOI: 10.1016/j.trecan.2018.09.002

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  9 in total

Review 1.  Tumour predisposition and cancer syndromes as models to study gene-environment interactions.

Authors:  Michele Carbone; Sarah T Arron; Bruce Beutler; Angela Bononi; Webster Cavenee; James E Cleaver; Carlo M Croce; Alan D'Andrea; William D Foulkes; Giovanni Gaudino; Joanna L Groden; Elizabeth P Henske; Ian D Hickson; Paul M Hwang; Richard D Kolodner; Tak W Mak; David Malkin; Raymond J Monnat; Flavia Novelli; Harvey I Pass; John H Petrini; Laura S Schmidt; Haining Yang
Journal:  Nat Rev Cancer       Date:  2020-05-29       Impact factor: 60.716

2.  Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations.

Authors:  Ying L Liu; Karen A Cadoo; Semanti Mukherjee; Aliya Khurram; Kaitlyn Tkachuk; Yelena Kemel; Anna Maio; Sami Belhadj; Maria I Carlo; Alicia Latham; Michael F Walsh; Marianne E Dubard-Gault; Yuhan Wang; A Rose Brannon; Erin Salo-Mullen; Margaret Sheehan; Elise Fiala; Bryan Devolder; Sita Dandiker; Diana Mandelker; Ahmet Zehir; Marc Ladanyi; Michael F Berger; David B Solit; Chaitanya Bandlamudi; Vignesh Ravichandran; Dean F Bajorin; Zsofia K Stadler; Mark E Robson; Joseph Vijai; Venkatraman Seshan; Kenneth Offit
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-11-22       Impact factor: 4.090

Review 3.  Primary Immunodeficiency and Cancer Predisposition Revisited: Embedding Two Closely Related Concepts Into an Integrative Conceptual Framework.

Authors:  Oskar A Haas
Journal:  Front Immunol       Date:  2019-02-12       Impact factor: 7.561

4.  Family history assessment significantly enhances delivery of precision medicine in the genomics era.

Authors:  Yasmin Bylstra; Weng Khong Lim; Sylvia Kam; Koei Wan Tham; R Ryanne Wu; Jing Xian Teo; Sonia Davila; Jyn Ling Kuan; Sock Hoai Chan; Nicolas Bertin; Cheng Xi Yang; Steve Rozen; Bin Tean Teh; Khung Keong Yeo; Stuart Alexander Cook; Saumya Shekhar Jamuar; Geoffrey S Ginsburg; Lori A Orlando; Patrick Tan
Journal:  Genome Med       Date:  2021-01-07       Impact factor: 11.117

Review 5.  Risk Factors for Childhood Leukemia: Radiation and Beyond.

Authors:  Janine-Alison Schmidt; Sabine Hornhardt; Friederike Erdmann; Isidro Sánchez-García; Ute Fischer; Joachim Schüz; Gunde Ziegelberger
Journal:  Front Public Health       Date:  2021-12-24

6.  Incidental germline findings during molecular profiling of tumor tissues for precision oncology: molecular survey and methodological obstacles.

Authors:  Alexandra Lebedeva; Yulia Shaykhutdinova; Daria Seriak; Ekaterina Ignatova; Ekaterina Rozhavskaya; Divyasphoorthi Vardhan; Sofia Manicka; Margarita Sharova; Tatiana Grigoreva; Ancha Baranova; Vladislav Mileyko; Maxim Ivanov
Journal:  J Transl Med       Date:  2022-01-15       Impact factor: 5.531

7.  Leveraging deep phenotyping from health check-up cohort with 10,000 Korean individuals for phenome-wide association study of 136 traits.

Authors:  Eun Kyung Choe; Manu Shivakumar; Anurag Verma; Shefali Setia Verma; Seung Ho Choi; Joo Sung Kim; Dokyoon Kim
Journal:  Sci Rep       Date:  2022-02-04       Impact factor: 4.379

8.  Case Report: A Rare Case of Autoinflammatory Phospholipase Cγ2 (PLCγ2)-Associated Antibody Deficiency and Immune Dysregulation Complicated With Gangrenous Pyoderma and Literature Review.

Authors:  Na Wu; Bingqing Zhang; Tao Wang; Min Shen; Xuejun Zeng
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

9.  Constitutional 2p16.3 deletion including MSH6 and FBXO11 in a boy with developmental delay and diffuse large B-cell lymphoma.

Authors:  N van Engelen; F van Dijk; E Waanders; A Buijs; M A Vermeulen; J L C Loeffen; R P Kuiper; M C J Jongmans
Journal:  Fam Cancer       Date:  2021-04-03       Impact factor: 2.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.